Remission of hepatitis B virus-related cryoglobulinemic vasculitis with entecavir

Annals of Internal Medicine

Volumn 149, Issue 12, 2008, Pages 911-912

  Kawakami, Tamihiro ^a   Ooka, Shiho ^a   Mizoguchi, Masako ^a   Soma, Yoshinao ^a   Yamazaki, Masahide ^b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL EXAMINATION; CRYOGLOBULINEMIC VASCULITIS; CRYOPRECIPITATE; DISEASE ASSOCIATION; ECHOGRAPHY; ELECTROMYOGRAPHY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOFLUORESCENCE TEST; JAPANESE; LETTER; MALE; MICROSCOPY; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME; VASCULITIS;

EID: 58049217346     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-149-12-200812160-00018     Document Type: Letter

References (3)

1. McMahon MA, Jilek BL, Brennan TP, Shen L, Zhou Y, Wind-Rotolo M, et al. The HBV drug entecavir - effects on HIV-1 replication and resistance. N Engl J Med. 2007;356:2614-21. [PMID: 17582071]
2. Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Stelter F, Peterson DL, et al. LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles. J Gen Virol. 2002;83:2279-89. [PMID: 12185283]
3. D'Agnillo P, Levine JS, Subang R, Rauch J. Prothrombin binds to the surface of apoptotic, but not viable, cells and serves as a target of lupus anticoagulant autoantibodies. J Immunol. 2003;170:3408-22. [PMID: 12626602] 912-913